Sodium Chloride 0.9% Carpuject and Vial Principal Display Panel

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

10 mL Single-dose
Rx only

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT.
Hospira

LOT ##-###-AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray

10 mL Single-dose

NDC 0409-4888-10
Contains 25 of NDC 0409-4888-02

Rx only

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray

PRINCIPAL DISPLAY PANEL - 20 mL Vial Label

20 mL Single-dose
Rx only
PRESERVATIVE-FREE

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT.

Hospira

LOT ##-###-AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 20 mL Vial Label

PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray

20 mL Single-dose

NDC 0409-4888-20
Contains 25 of NDC 0409-4888-03

Rx only

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT

Hospira

PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

50 mL Single-dose
Rx only
PRESERVATIVE-FREE

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT.

Hospira

LOT ##-###-AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray

50 mL Single-dose

NDC 0409-4888-50
Contains 25 of NDC 0409-4888-06

Rx only

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT

Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - LifeShield

10 mL Single-dose
Rx only
PRESERVATIVE-FREE

LIFESHIELD®
Vial

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT.

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - LifeShield

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - LifeShield

10 mL Single-dose
LIFESHIELD®
Vial

NDC 0409-4888-12
Contains 25 of NDC 0409-4888-01

Rx only

0.9% Sodium Chloride
Injection, USP

FOR USE AS A STERILE DILUENT

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - LifeShield

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Label

2 mL Single-dose Carpuject™
Sterile Cartridge Unit with Luer Lock

Preservative-Free
0.9% Sodium Chloride
Injection, USP

Dist. by Hospira, Inc., Lake Forest, IL 60045 USA

Rx only

NDC 0409-1918-42

PAA140972

Hospira

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Container Label

2 mL Single-dose
Preservative-Free
50 Carpuject™ Sterile Cartridge Units
with Luer Lock
Needle not included

NDC 0409-1918-32
Rx only

0.9% Sodium Chloride
Injection, USP

Carpuject Cartridges are to be used ONLY with
Carpuject Holders.

Each CARPUJECT Sterile Cartridge Unit contains 2 mL of a sterile
isotonic solution of Sodium Chloride Injection, USP, 0.9%, and
has a total osmolar concentration of 0.31 mOsmol/mL. Each mL
contains 9 mg of sodium chloride.
Do not use if solution is discolored or contains a precipitate.
Sterile Aqueous Injection.
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room
Temperature.]

Do not freeze.
PAA116988

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Container Label

PRINCIPAL DISPLAY PANEL - 3 mL Cartridge Label

3 mL Single-dose Carpuject™
Sterile Cartridge Unit with Luer Lock

Preservative-Free
0.9% Sodium
Chloride
Injection, USP

Dist. by Hospira, Inc., Lake Forest, IL 60045 USA

NDC 0409-1918-43
Rx only

PAA140974

Hospira

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 3 mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 3 mL Cartridge Container Label

3 mL Single-dose
Preservative-Free
NDC 0409-1918-33

Rx only

25 Carpuject™ Sterile Cartridge Units
with Luer Lock

Needle not included

0.9% Sodium Chloride
Injection, USP

Carpuject Cartridges are to be used ONLY
with Carpuject Holders.

Each CARPUJECT Sterile Cartridge Unit contains 3 mL of
a sterile isotonic solution of Sodium Chloride Injection,
USP, 0.9%, and has a total osmolar concentration of
0.31 mOsmol/mL. Each mL contains 9 mg of sodium chloride.
Do not use if solution is discolored or contains a precipitate.
Sterile Aqueous Injection.
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room
Temperature.]

Do not freeze.
PAA116990

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 3 mL Cartridge Container Label

PRINCIPAL DISPLAY PANEL - 5 mL Cartridge Label

5 mL Single-dose Carpuject™
Sterile Cartridge Unit with Luer Lock

Preservative-Free
0.9% Sodium
Chloride
Injection, USP

Dist. by Hospira, Inc., Lake Forest, IL 60045 USA

NDC 0409-1918-45
Rx only

PAA140975

Hospira

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 5 mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 5 mL Cartridge Container Label

5 mL Single-dose
Preservative-Free

25 Carpuject™ Sterile Cartridge Units
with Luer Lock

Needle not included

NDC 0409-1918-35
Rx only

0.9% Sodium Chloride
Injection, USP

Carpuject Cartridges are to be used ONLY
with Carpuject Holders.

Each CARPUJECT Sterile Cartridge Unit contains 5 mL of a sterile
isotonic solution of Sodium Chloride Injection, USP, 0.9%, and
has a total osmolar concentration of 0.31 mOsmol/mL. Each mL
contains 9 mg of sodium chloride.
Do not use if solution is discolored or contains a precipitate.
Sterile Aqueous Injection.
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room
Temperature.]

Do not freeze.
PAA116992

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 5 mL Cartridge Container Label

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Sodium Chloride 0.9% Carpuject and Vial Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be...

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

The volume of the preparation to be used for diluting or dissolving any drug for injection, is dependent on the vehicle concentration, dose and route of administration as recommended by the...

Did you find an answer to your question? Yes No

PRECAUTIONS

Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.

Inspect reconstituted (...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the...

Did you find an answer to your question? Yes No

OVERDOSAGE

Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of carbohydrate, sodium chloride or fluid overload except possibly in neonates or very small infants. In the event these...

Did you find an answer to your question? Yes No

DESCRIPTION

This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection.

0.9% Sodium Chloride Injection, USP...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl‾) ions. These ions are normal constituents of the body fluids (principally extracellular) and are...

Did you find an answer to your question? Yes No

HOW SUPPLIED

0.9% Sodium Chloride Injection, USP is supplied in the following:

...

Did you find an answer to your question? Yes No

Injection, USP

Carpuject™ with Luer Lock
Fliptop Plastic Vial...

Did you find an answer to your question? Yes No

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.